December 2022
12/15/22
Presented by Zita Aretz
“Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells.”
November 2022
11/17/22
Presented by Jaeyop Lee
“Quantitative immunopeptidomics reveals a tumor stroma–specific target for T cell therapy.”
11/10/22
Presented by Kristen Vogt
“Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.”
September 2022
9/29/22
Presented by Pedro Silberman
“Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory.”
9/22/22
Presented by Manish Malviya
“A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease.”
9/1/22
Presented by Keifer Kurtz
“SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling.”
August 2022
8/18/22
Presented by Zaki Molvi
“T cells discriminate between groups C1 and C2 HLA-C.”
8/11/22
Presented by Michael Lau
“Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation.”
June 2022
6/09/22
Presented by James Han
“Neoantigen T-Cell Receptor Gene Therapy in Pancreating Cancer.”
6/02/22
Presented by Patrick Wallisch
“The immunostimulatory RNA RN7SL1 enables CAR T cells to enhance autonomous and endogenous immune function.”
May 2022
5/05/2022
Presented by Winson Cai
“A genome-scale screen for synthetic drivers of T cell proliferation.”
April 2022
4/28/2022
Presented by Kristen Vogt
“Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.”
“Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the treatment of Acute Lymphoblastic Leukemia.”
4/21/2022
Presented by Zita Aretz
“Tryptophan depletion results in tryptophan-to-phenylalanine substitutants.”
4/14/2022
Presented by Shireen Khayat
“SIRPy-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of CHronic Stimulation.”
March 2022
3/17/2022
Presented by Zaki Molvi
“CRISPR activation and interference screens decode stimulation responses in primary human T cells.”
“Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency.”
February 2022
2/10/2022
Presented by Pedro Cito Silberman
“A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors.”
January 2022
1/13/2022
Presented by Winson Cai
“A human orthogonal IL-2 and IL-2R system enhances CAR T cell expansion and antitumor activity in amurine model of leukemia.”
1/06/2022
Presented by Anqi [Nora] Zhou
“Natural killer cell receptors regulate responses of HLA-E-restricted T cells.”